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Background: Smokers who continue to smoke up to the point of surgery are at
increased risk of a range of complications during and following surgery.
Objective: To identify whether behavioral and/or pharmacological interventions increase
the likelihood that smokers quit prior to elective surgery and which intervention
components are associated with larger effects.
Design: Systematic review with meta-analysis.
Data sources: MEDLINE, Embase, and Embase Classic, CINAHL, CENTRAL.
Study selection: Studies testing the effect of smoking reduction interventions delivered
at least 24 h before elective surgery were included.
Study appraisal and synthesis: Potential studies were independently screened by two
people. Data relating to study characteristics and risk of bias were extracted. The effects
of the interventions on pre-operative smoking abstinence were estimated using random
effects meta-analyses. The association between specific intervention components
(behavior change techniques; mode; duration; number of sessions; interventionist) and
smoking cessation effect sizes were estimated using meta-regressions.
Results: Twenty-two studies comprising 2,992 smokers were included and 19
studies were meta-analyzed. Interventions increased the proportion of smokers who
were abstinent or reduced smoking by surgery relative to control: g = 0.56,
95% CI 0.32–0.80, with rates nearly double in the intervention (46.2%) relative
to the control (24.5%). Interventions that comprised more sessions, delivered
face-to-face and by nurses, as well as specific behavior change techniques
(providing information on consequence of smoking/cessation; providing information
on withdrawal symptoms; goal setting; review of goals; regular monitoring by others;
and giving options for additional or later support) were associated with larger effects.
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Conclusion: Rates of smoking can be halved prior to surgery and a number of
intervention characteristics can increase these effects. There was, however, some
indication of publication bias meaning the benefits of such interventions may be smaller
than estimated.
Registration: Prospero 2015: CRD42015024733
Keywords: smoking, smoking cessation, pre-operative, systematic review, meta-analysis, behavior change
technique, mode, intervention
INTRODUCTION
Although tobacco use is decreasing [Action on Smoking and
Health (ASH), 2016], around one in three patients who undergo
elective surgery use tobacco (Kleinwächter et al., 2010; Bradley
et al., 2011). This is an important issue because pre-operative
smoking can increase the length of hospital stay (Lavernia et al.,
1999; Barrera et al., 2005; London Health Observatory, 2016),
as well as mortality (based on adjusted risk ratios only), general
morbidity, general infections, wound complications, pulmonary
complications, neurological complications, and the likelihood of
being admitted to intensive care following operation (Grønkjær
et al., 2014). However, there is evidence that smoking cessation
can be achieved before surgery and that, when attained through
intensive, multi-session interventions, there are also reductions
in general complications and wound complications (Thomsen
et al., 2014).
While Thomsen et al.’s (2014) review demonstrated that both
brief and intensive interventions helped to achieve pre-operative
smoking cessation with intensive interventions particularly
effective, it did not elucidate other active ingredients underlying
these increased rates. These characteristics could include those of
the person delivering the intervention, the mode of delivery, or
the behavior change techniques (BCTs) incorporated.
Taxonomies of behavior change techniques (Michie et al.,
2013) comprising standardized descriptions of intervention
components have been recently developed, encouraging a
systematic approach to intervention development and explicit
reporting. Just as biochemists explain the molecular structure
of medicines, and their biological mechanisms, behavioral-
scientists must define the structure of their interventions, and
mechanisms by which they modify behavior. Individual behavior
change techniques (BCTs) are the smallest “active ingredients”
of a behavioral intervention package that are compatible with
retaining a specified mechanism of action (Michie et al., 2015).
While the specific BCTs effective in smoking interventions for
those attending Stop Smoking Services in England (West et al.,
2010) or for those with COPD (Bartlett et al., 2014) have
been identified, this is not the case for those awaiting surgery.
Moreover, beyond BCTs, group interventions have been linked
with higher success rates than one-to-one interventions (Brose
et al., 2011) but it is not clear whether this approach would be
effective in pre-operative contexts.
There is thus evidence that pre-operative smoking cessation
support is needed to improve surgical outcomes (“pre-operative
services should intervene”), but considerable uncertainty over
what the best support is in this setting (“how pre-operative
services should intervene”). Consequently, the first aim of this
review was to characterize the BCTs and other intervention
characteristics used in pre-operative intervention studies, and
identify, via meta-regression, those associated with higher
rates of pre-operative smoking cessation. Second, given the
possibility that seemingly effective characteristics, including
behavior change techniques, may be confounded with one
another (Prestwich et al., 2014, 2016; Peters et al., 2015), we
accounted for such potential confounds in the analyses. Third,
we extended previous reviews that only incorporated randomized
controlled trials (Mills et al., 2011; Thomsen et al., 2014) by also
including quasi-experimental trials and single group (pre-post)
designs. Fourth, we assessed whether features of study quality and
publication bias could impact on the summary estimates, given
study quality can bias estimates of effects (Detsky et al., 1992;
Prestwich et al., 2014, 2016).
METHODS
The review was registered at Prospero CRD42015024733 and
follows the PRISMA reporting guidelines.
Eligibility Criteria
Studies were included if (1) they tested the effect of an
intervention (behavioral and/or pharmacological) to reduce
smoking; (2) in smokers scheduled for elective surgery and (3) a
measure of their smoking in the pre-operative period was taken.
Studies were excluded if (1) the intervention was delivered in the
intra-operative or post-operative periods only (in particular, the
intervention had to begin at least 24 h before surgery); (2) it was a
review or commentary; (3) was not published in English; (4) the
article was an abstract or dissertation.
Electronic Searches
MEDLINE (1946-) and Embase Classic + Embase (1947-) were
searched via OVID. We also searched CINAHL and CENTRAL.
The search terms were based on those used by Thomsen et al.
(2014) but with study design terms added (Lancaster et al., 2013)
to capture non-RCT designs (see Table 1 for our MEDLINE
search terms). Where eligible studies referred to associated
papers for further methodological, statistical, or intervention-
related details, these associated papers were retrieved and used
for coding purposes. The searches were last run on the 27th
September, 2014.
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TABLE 1 | MEDLINE search strategy via OVID.
1. Randomized Controlled Trial.pt.
2. Controlled Clinical Trial.pt.
3. Clinical Trial.pt.
4. Exp Clinical trial/
5. Random Allocation/
6. Randomized controlled trials/
7. Double blind method/
8. Single blind method/
9. Placebos/
10. Research Design/
11. (clin$ adj5 trial$ or placebo$ or random$).ti,ab.
12. ((singl$ or doubl$ or trebl$ or tripl$) adj5 (blind$ or mask$)).ti,ab.
13. (volunteer$ or prospectiv$).ti,ab.
14. exp Follow Up Studies/
15. exp Retrospective Studies/
16. exp Prospective Studies/
17. exp Evaluation Studies/or Program Evaluation.mp.
18. exp Cross Sectional Studies/
19. exp Behavior therapy/
20. exp Health Promotion/
21. exp Community Health Services/
22. exp Health Education/
23. exp Health Behavior/
24. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or
15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 or 23
25. smoking cessation.mp. or exp Smoking cessation/
26. “Tobacco-Use-Cessation”/
27. “Tobacco-Use-Disorder”/
28. exp Smoking/pc, th
29. (surgery or operation or operativ: or an?esthesia).mp.
30. exp Postoperative complication/
31. exp Preoperative care/
32. exp Patient education/
33. 30 and (31 or 32)
34. 29 or 33
35. 25 or 26 or 27 or 28
36. 24 and 34 and 35
Study Selection
All records were screened independently by two raters at all
stages (titles/abstracts; full-texts). Studies identified as eligible
for possible inclusion by either reviewer at the title/abstract
stage were included in the full-text screening. Discrepancies were
resolved through discussion.
Data Extraction
The lead author coded all of the studies meeting the
inclusion/exclusion criteria. To maximize reliability, all elements
of data extraction (including effect size calculations) were
checked by the last author. Both reviewers were experienced
in conducting systematic reviews, had been formally trained in
coding behavior change techniques during the development of
an extensive list of behavior change techniques (Michie et al.,
2013) and were qualified up to PhD level. With the exception of
BM10 in the experimental condition (1 disagreement, kappa= 0)
and face-to-face delivery in the experimental condition (2
disagreements, kappa = 0.46) all inter-rater reliabilities for the
categorical predictors were at least substantial (range: 0.65–1).
Disagreements were resolved in consultation with a third
reviewer.
The behavior change techniques (BCTs), other aspects of the
intervention (duration; number of sessions; mode of delivery;
interventionist), participants (type of surgery; country), design,
measures, and risk of bias were coded. BCTs were identified in
the treatment and comparison groups using a reliable taxonomy
comprising descriptions of 44 smoking-specific techniques
(Michie et al., 2011). To enable comparison with other reviews
and studies, we have labeled the BCTs as recommended byMichie
et al. (2011) within the results tables and within the text (e.g., BS9
Set graded tasks represents setting small achievable goals where
appropriate (e.g., take 1 day at a time); see Michie et al. (2011) for
full definitions of all behavior change techniques). Extra BCTs not
covered in this taxonomy (e.g., self-talk) were also coded. Risk of
bias was considered using the Cochrane Risk of Bias Tool.
Data Analysis
Effect sizes (g) for each study were calculated using
Comprehensive Meta-Analysis (Borenstein et al., 2005).
Effect sizes were calculated based on the proportion of patients
who were abstinent pre-surgery relative to the number of
patients randomized to each condition (i.e., an intention-to-treat
approach). Where abstinence was not reported, a measure of
smoking reduction was used as the basis for the effect size
calculation.
STATA version 13.1 (StataCorp, 2013) was used to conduct
random-effects meta-analyses and random effects meta-
regressions. Meta-analyses examined the extent to which
pre-operative smoking cessation can be achieved through
intervention. Meta-regressions tested which intervention
components and other study features were associated with effect
sizes.
Further analyses tested how the results changed when
accounting for: trial design (i.e., RCTs only, sensitivity
analysis 1); the potential impact of risk of bias (sensitivity
analysis 2); confounding between BCTs (sensitivity analysis 3);
confounding between BCTs and other intervention
characteristics (sensitivity analysis 4); confounding between
other intervention characteristics (sensitivity analysis 5).
Chi-square analyses were conducted to examine associations
between effective intervention components that were assessed
categorically (BCTs; interventionist; mode) while Pearson’s
correlation assessed the associations between these categorical
variables and other effective intervention characteristics
(duration of intervention; number of sessions). When pairs
of BCTs/intervention characteristics where related, they
were entered simultaneously as predictors of effect sizes
of smoking abstinence in multivariate meta-regressions.
If either or both of the BCTs/intervention characteristics
were significant in these meta-regressions, this would
suggest that the BCTs/intervention characteristics influence
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smoking abstinence over and above the co-varied feature.
If both are non-significant then it is unclear which of
the intervention components are effective due to issues of
confounding.
The risk of publication bias was assessed using Egger’s
regression (Egger et al., 1997) and a funnel plot. Duval and
Tweedie’s (2000) trim and fill analysis estimated the impact
of publication bias on effect sizes indicating the effect of the
interventions on pre-operative smoking cessation.
RESULTS
Twenty-two studies met the eligibility criteria compared to 13
RCTs included in Thomsen et al.’s (2014) review. Of the 22
eligible studies, 19 were subjected to meta-analysis (three studies
used single group pre-post design; see Figure 1). Of these 19
studies, 16 were RCTs and 3 were quasi-experimental studies.
Two further studies were identified as eligible but did not report
sufficient data in order to calculate effect sizes (Bradley et al.,
FIGURE 1 | PRISMA Flow Diagram.
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2013; Hiramatsu et al., 2014). These studies are not discussed
further.
Study Characteristics
The studies were conducted in the USA/Canada (k = 8), UK
(k = 6), Denmark/Sweden (k = 5), and Australia (k = 3) (see
Table 2). On average, the interventions were delivered over a
period of 28 days (median = 8 days) and involved 2.33 sessions
(median = 1; 56% (10/18 studies) used a single session; 4
unclear). The majority of interventions were delivered face-to-
face (86%; 19/22) and used written or printed materials (59%;
10/17; 5 unclear). Half of the studies delivered at least part of the
intervention using the telephone (50%; 10/20; 2 unclear); fewer
studies delivered at least part of the intervention through the
internet or computer (19%; 3/16; 6 unclear) or mail (7%; 1/15; 7
unclear). The interventions were delivered by nurses (69%; 11/16;
6 unclear), anesthetists (19%; 3/16), clinicians other than nurses
(38%; 6/16), and researchers (19%; 3/16). About a third delivered
the intervention through a team of people (31%; 5/16). None of
the interventions were delivered to groups of patients. Studies
required participants to not smoke for 7 days (mean average)
in order to be classified as abstinent (although the median was
1 day).
Aside from the techniques related to measuring smoking
behavior or history, the most common BCTs delivered to the
intervention group during the pre-operative period were: BS4
Facilitate goal-setting (82%); BM11 Measure carbon monoxide
(59%); Ext2 Provide NRT, buproprion or varenicline (50%); A3
Adopt appropriate local procedures to enable clients to obtain
free medication (46%); A5 Give options for additional and
later support (46%); BM1 Provide information on consequences
of smoking and smoking cessation (41%), and BM2 Boost
motivation and self-efficacy (32%).
Can Smoking Abstinence be Achieved
Pre-operatively?
The results suggest that rates of smoking reduction can be
positively influenced with a medium effect size, g = 0.56, 95%
CI 0.32–0.80 (see Figure 2), with rates nearly double in the
intervention (46.2%) relative to the control (24.5%), based on 19
studies. However, there was significant heterogeneity, I2= 76.6%;
Q(18) = 76.94, p < 0.001. When the analyses were repeated only
on RCTs (intervention: 46.4% vs. control: 24.5%, based on 16
studies) or quasi-experiments (intervention: 44.5% vs. control:
24.4%, based on 3 studies) or the single group design studies
(intervention: 37.9%, based on 3 studies), the rates remained
similar.
The majority of study effect sizes reflected rates of abstinence
(k = 17) rather than reduced smoking (k = 2). The overall effect
of the interventions on abstinence rates remained medium sized,
g = 0.48, 95% CI 0.25–0.72 (intervention: 42.1% vs. control:
23.7%, k= 17; RCTs only: intervention: 44.2% vs. control: 25.3%,
k = 15; quasi-experiments only: intervention: 26.7% vs. control:
11.6%, k = 2; single group designs: intervention: 37.9%, k = 3).
From here, the term abstinence is used to refer to the outcomes
from all 19 trials. There was an association between the number of
days prior to surgery that patients were asked to remain abstinent
and the intervention effect sizes; studies that attempted to achieve
abstinence further away from the surgery date achieved larger
effect sizes, B = 0.03, SE = 0.01, 95% CI 0.007–0.06, p = 0.02.
The magnitude of the intervention effects did not vary depending
on whether the self-reported smoking outcomes were verified
biochemically or not, B = 0.08, SE = 0.32, 95% CI −0.58–0.75,
p= 0.80.
In the single group (pre-post) design studies, the following
percentages of participants self-reported that they had stopped
smoking prior to surgery:Walker et al. (2009) (16/25; 64%); Haile
et al. (2002) (22/56; 39%); Kunzel et al. (2012) (9/38; 28%- but this
fell to 13% when biochemically verified).
Features of Interventions that Achieve
Higher Rates of Abstinence
Behaviour Change Techniques
The following six behavior change techniques were associated
with higher rates of smoking abstinence: “Provide information
on consequences of smoking and smoking cessation” (BM1);
“Facilitate goal setting” (BS4); “Prompt review of goals” (BS5);
“Regular monitoring by others” (BS6b); “Give options for
additional and later support” (A5); and, “Provide information
on withdrawal symptoms” (RC6) (Table 3). However, “Facilitate
goal setting” (BS4) only reached conventional levels of
significance when the analyses were based only on the RCTs and
“Prompt review of goals” (BS5) was only marginally significant
when either based on all trials or only on RCTs. From the studies
that employed a single group (pre-post) design, it is interesting
to note that the study that reported the highest rate of abstinence
(Walker et al., 2009), few BCTs were employed but, of these, two
were BCTs identified as being effective in the experimental trials
[“Facilitate goal setting” (BS4); “Give options for additional and
later support pre-surgery” (A5)].
Other Intervention Characteristics
Longer delivery and more intervention sessions for the
experimental group yielded larger effect sizes, as did face-to-face
delivery, using modes of delivery other than print, and delivery
of the intervention by a nurse (Table 4). Of the studies that used
a single group (pre-post) design, Haile et al.’s (2002) intervention
was delivered via a computer (and achieved 39.3% abstinence),
while Walker et al. (2009) who reported a much higher rate of
abstinence (64.0%) was delivered face-to-face. Although Kunzel
et al. (2012), who reported much lower rates of abstinence
(10.5%) also delivered their intervention face-to-face, they also
used telephone delivery and print-based materials.
Sensitivity Analyses
Sensitivity Analyses 1: Randomized Controlled Trials
Only
The effects of the BCTs on smoking abstinence effect sizes were
largely unaffected by whether or not the study design was a
randomized controlled trial (k = 16). Specifically, all of the
significant BCTs remained significant and the non-significant
BCTs remained non-significant. The only exception was “Goal
setting” (BS4) which became significant rather than marginally
significant (Table 3).
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TABLE 2A | Characteristics of included studies.
Study Design Scheduled surgery Country BCTs (experimental) BCTs (comparison) %Abstinent
Expt. Control
Andrews et al., 2006 RCT Unclear UK BM1b; A5; RI1,2; Ext1 BM1b; A5; RI1,2 35.3 15.7
Haddock and Burrows,
1997
Quasi General/
Gynecology
UK BM1,9; BS6,7; A2,5; RI1,2,3;
RC1,2,7,10; Ext1,8
RI1,2,3; 80.0a 50.0a
Haile et al., 2002 Single group Non-cardiac Australia BM1,6; BS1,4,7,8; A2; RD1; RI1,2;
RC8; Ext1,8,9
n/a 39.3 n/a
Kunzel et al., 2012 Single group Various USA BM1b,2,11;BS4; A5;RI1,2,3 n/a 10.5 n/a
Lee et al., 2013 RCT Any surgery Canada BM1,2,6,8,9,11; A1,2,3,5;
BS1,2,3,4,6,7,8,9,10,11; RD1,2;
RI1,3; RC:5,6,10; Ext:1,2,4
BM11; RI1 14.3 3.6
Lindström et al., 2008 RCT Hip/knee/hernia/
laparoscopic
cholecystectomy
Sweden BM1,2,11; BS4,5,6b; A3,5; RI1; Ext2 BM11; RI1 36.4 1.6
McHugh et al., 2001 RCT Coronary artery
bypass grafting
UK BM1,9; A5; RD1; RI1,2; RC8 RI1 92.3 10.0
Møller et al., 2002 RCT Hip/knee Denmark BM1,11; BS4,5,6b; A3; RI1; RC2,6;
Ext2,3
RI1 60.0 6.7
Munday et al., 1993 Quasi Unclear UK BM1c; BS4; RI1; Ext1 RI1 7.4 9.3
Myles et al., 2004 RCT Various Australia BM1c;2c,11; BS4; RI1,3; Ext1,2 BM1c,2c,11; BS4;
RI1,3; Ext1
4.2 4.3
Ostroff et al., 2014 RCT Cancer USA BM1,2,11; BS1,4,9; A1,3; RD1;
RI1,2; RC2; Ext2,5
BM1,2,11; BS1,4; A1,3;
RI1,2; Ext2,5
44.8 44.9
Ratner et al., 2004 RCT Various Canada BM1,11; BS4,10; A2,3,5; RI1,2;
Ext1,2,6
BM11; RI1,2 69.2 51.7
Shah et al., 1984 Quasi Various UK BS4,6; RI1 none 46.0 14.0
Shi et al., 2013 RCT Unclear USA BM1,2b,11; BS4; RI1,2,3; RC3; Ext1 BM1,2b,11; BS4;
RI1,2,3; Ext1
79.3 74.7
Sørensen and
Jørgensen, 2003
RCT Open colonic/rectal
procedure
Denmark BM11; BS4; A3,5; RI1; Ext2 BM11; RI1 80.0a 13.3a
Sørensen et al., 2007 RCT Herniotomy Denmark BM1c,11; BS4,5; A3; RI1,2; Ext1,2 BM1c,11; BS4; RI1,2;
Ext1
19.2 10.0
Thomsen et al., 2010 RCT Breast cancer Denmark BM2,9,11; BS4; RI1,3; Ext5 BM11; RI1,3 24.6 10.8
Walker et al., 2009 Single group Forefoot osteotomy or
arthrodesis
UK BM1c; BS4; A5; Ext1 n/a 64.0 n/a
Warner et al., 2011 RCT Various USA BM1b; BS4; A5; RI1,3;Ext1 A1,2,5; RI1,3; RC6;
BM1,9,10; BS4,8;
6.7 11.9
Warner and Kadimpati,
2012
RCT Various USA BM1b,11; BS3,4; A3; RI1,2,4; Ext2 BM1b,11; BS3,4;
RI1,2,4
72.7 54.2
Wolfenden et al., 2005 RCT Non-cardiac Australia BM2; A2,3; RD1; RI1,2,3; Ext2,7 RI1,2,3 74.2 59.3
Wong et al., 2012 RCT Various Canada BM1b,2,11; BS2,4; A3; RI1,2,3; Ext2 BM1b,2,11; BS2,4;
RI1,2,3
29.8 20.0
aFigures represent self-reported rates of reduced smoking. RCT, Randomized Controlled Trial; Quasi, Quasi-experimental trial; single group, Pre-post design with a single condition.
Expt, Experimental group. BCTs (Experimental) represent the behavior change techniques delivered to the experimental group. BCTs (Comparison) represent the behavior change
techniques delivered to the comparison condition. BCTs are those delivered, at least in part, pre-operation. BCTs delivered exclusively to either the intervention or control groups are
underlined. BM1 Provide information on consequences of smoking and smoking cessation; BM2 Boost motivation and self-efficacy; BM6 Prompt commitment from the client there and
then; BM9 Identify reasons for wanting and not wanting to stop smoking; BM10 Explain the importance of abrupt cessation; BM11 Measure CO; BS1 Facilitate barrier identification
and problem solving; BS2 Facilitate relapse prevention and coping; BS3 Facilitate action planning/develop treatment plan; BS4 Facilitate goal setting; BS5 Prompt review of goals;
BS6 Prompt self-recording; BS7 Advise on changing routine; BS8 Advise on environmental restructuring; BS9 Set graded tasks; BS10 Advise on conserving mental resources; BS11
Advise on avoiding social cues for smoking; A1 Advise on stop-smoking medication; A2 Advise on/facilitate use of social support; A3 Adopt appropriate local procedures to enable
clients to obtain free medication; A5 Give options for additional and later support; RD1 Tailor interactions appropriately; RD2 Emphasize choice; RI1 Assess current and past smoking
behavior; RI2 Assess current readiness and ability to quit; RI3 Assess past history of quit attempts; RI4 Assess withdrawal symptoms; RC1 Build general rapport; RC2 Elicit and answer
questions; RC3 Explain the purpose of CO monitoring; RC5 Offer/direct toward appropriate written materials; RC6 Provide information on withdrawal symptoms; RC7 Use reflective
listening; RC8 Elicit client views; RC10 Provide reassurance. Additional BCTs (not included within Michie et al. (2011) original taxonomy): BM1b, Variant on BM1 but only refers to the
benefits; BM1c, Variant on BM1 but only refers to the harms; BM2b, Variant on BM2 targeting self-efficacy only; BM2c, Variant on BM2 targeting motivation only; BS6b, Variant on BS6
but refers to regular monitoring by others; Ext1, Benefits/harms specified in context of pre-op; Ext2, NRT, Verenicline or Buproprion provided; Ext3, Advise on keeping weight gain to
a minimum; Ext4, Self-talk; Ext5, Motivational interviewing; Ext6, BCTs for dealing with cravings and high-risk situations; Ext7, Skills training/practical counseling; Ext8, Directed to NRT
but not provided; Ext9: contracts.
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TABLE 2B | Characteristics of included studies.
Study Delivery (experimental) Delivery (comparison)
Days Sessions Mode Person delivering Days Sessions Mode Person delivering
Andrews et al., 2006 1 1 F2F; Print Nurse; surgeon 1 1 F2F; Print Nurse
Haddock and
Burrows, 1997
10.5 1 F2F; Print Nurse 1 1 Print Nurse
Haile et al., 2002 1 1 Computer n/a n/a n/a n/a n/a
Kunzel et al., 2012 unclear 2 F2F; Phone;
Print
Urologist n/a n/a n/a n/a
Lee et al., 2013 21 5 F2F; Phone;
Print
Nurse +
surgeon/anesthetist
Unclear Unclear Unclear Nurse, surgeon, or
anesthetist
Lindström et al., 2008 28 4 F2F; Phone Nurse Unclear Unclear Unclear Unclear
McHugh et al., 2001 243 8 F2F; Phone Nurse 243 Unclear Unclear Unclear
Møller et al., 2002 49 7 F2F Nurse Unclear Unclear Unclear Unclear
Munday et al., 1993 1 1 Print Unclear 0 0 n/a n/a
Myles et al., 2004 49 2 F2F; Print Unclear 49 1 F2F; Print unclear
Ostroff et al., 2014 7 2 F2F; Computer;
Phone; Print
Nurse + researcher 7 2 F2F; Phone Nurse
Ratner et al., 2004 14 1 F2F; Phone Nurse 1 1 F2F Nurse
Shah et al., 1984 1 1 Mail; Print Unclear 0 0 n/a n/a
Shi et al., 2013 1 1 F2F (Anesthetist, internist,
physician assistant) +
researcher
1 1 F2F (Anesthetist, internist,
physician assistant) +
researcher
Sørensen and
Jørgensen, 2003
17.5 Unclear F2F; Phone Nurse 1 1 F2F Nurse
Sørensen et al., 2007 Unclear 2 F2F; Phone Nurse 1 1 Unclear Unclear
Thomsen et al., 2010 5 1 F2F Unclear 1 1 F2F Unclear
Walker et al., 2009 Unclear Unclear F2F Unclear n/a n/a n/a n/a
Warner et al., 2011 Unclear Unclear F2F; Phone;
Print
Clinician Unclear Unclear F2F; Print Clinician
Warner and
Kadimpati, 2012
2 1 F2F Unclear 1 1 F2F Unclear
Wolfenden et al., 2005 Unclear Unclear F2F; Computer Nurse + anesthetist Unclear Unclear F2F Nurse + anesthetist
Wong et al., 2012 8 1 F2F; Phone;
Print
Researcher 8 1 F2F; Phone;
Print
Researcher
Days/sessions represent the number of days/sessions that participants received behavior change techniques designed to reduce their smoking behavior; mode represents how
the behavior change techniques were delivered; F2F, Face-to-face; Person delivering indicates the individual/s who delivered the behavior change techniques; n/a, not applicable;
Experimental represents the experimental condition; Comparison represents the comparison condition.
Sensitivity Analyses 2: Does Risk of Bias Influence
Effect Sizes?
The studies were at variable risk of bias (Table 5). For example,
most studies were at low risk of bias from inadequate
randomization but none of the studies were at low risk of
bias from selective reporting. Potential methodological quality
confounds were examined by establishing whether the risk
of bias indices were associated with effect size. None of the
risk of bias indices (randomization, allocation concealment,
blinding, selective outcome reporting, or incomplete data) were
associated with effect sizes. This suggests the intervention
characteristics associated with higher rates of smoking
abstinence were unlikely to have been influenced through
differential use within methodologically better (or poorer)
studies.
Sensitivity Analyses 3: Are the Effects of the BCTs on
Smoking Abstinence Effect Sizes Confounded by
other BCTs?
“Goal setting” (BS4) was delivered independently of the other
BCTs so its effects on smoking abstinence appeared not to
have been confounded by other BCTs. “Regular monitoring by
others” (BS6b) was only related to “Review of goals” (BS5)
but it still marginally predicted smoking abstinence, B =
1.35, SE = 0.70, 95%CI-0.15–2.84, p = 0.07, when controlling
for BS5. However, “Provide information on smoking/cessation
consequences” (BM1) no longer predicted smoking abstinence
when controlling for either “Give options for extra support”
(A5) or “Provide information on withdrawal symptoms” (RC6).
Similarly, “Review of goals” (BS5) and “Provide information
on withdrawal symptoms” (RC6) were both non-significant
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FIGURE 2 | Forest Plot.
when controlling for “Provide information on smoking/cessation
consequences” (BM1). Associations between the variables are
reported in Table 6.
Sensitivity Analyses 4: Are the Effects of BCTs on
Smoking Abstinence Effect Sizes Confounded by
other Important Intervention Characteristics?
“Goal setting” (BS4) was not related to any feature of
the intervention that was significantly related with smoking
abstinence effect sizes. The other effective BCTs were related to
some extent to other intervention characteristics (see Table 6)
that were predictive of smoking abstinence effect sizes (see
Table 4). In multivariate meta-regressions, “Provide information
on smoking/cessation consequences” (BM1) became amarginally
significant predictor of smoking abstinence effect sizes when
controlling for nurse delivery, B= 0.59, SE= 0.28, 95%CI-0.008–
1.19, p = 0.05. However, all of the other BCTs [aside from “Goal
setting” (BS4)] were rendered non-significant when controlling
for other relevant intervention characteristics (i.e., those that
predict effect sizes and were also associated with the BCT).
Sensitivity Analyses 5: Are the Effects of other
Intervention Characteristics on Smoking Abstinence
Effect Sizes Confounded?
The benefit of using other modes of delivery instead of print is
unlikely to be confounded by other intervention characteristics
given these variables were unrelated (see Table 6). Intervention
characteristics, other than BCTs, that were associated with
smoking abstinence effect sizes were otherwise inter-correlated.
Of these variables, the number of sessions delivered to the
experimental group remained predictive of smoking abstinence
effect sizes after controlling for delivery of the intervention by the
nurse, B= 0.22, SE= 0.07, 95% CI 0.07–0.36, p= 0.006, delivery
of the intervention by the nurse relative to the comparison group,
B= 0.17, SE= 0.08, 95% CI 0.00–0.34, p= 0.049, and marginally
significant when controlling for duration of intervention, B =
0.17, SE = 0.08, 95% CI-0.01–0.34, p = 0.06, and face-to-face
delivery, B= 0.17, SE = 0.08, 95% CI-0.01–0.34, p= 0.06. Nurse
delivery in the experimental group rather than the comparison
group significantly predicted smoking abstinence effect sizes after
controlling for delivery duration, B = 1.13, SE = 0.48, 95%CI
0.08–2.17, p = 0.04. No other predictors were significant in this
set of sensitivity analyses.
Publication Bias
Egger’s regression coefficient was significant suggesting some
evidence of publication bias (p = 0.03; Figure 3). Duval and
Tweedie’s (2000) trim and fill analysis imputed 6 additional effect
sizes for the effect of the interventions on smoking outcomes,
resulting in an overall effect size of g = 0.26 (CI=−0.004−0.53).
Thus, after the trim and fill analysis was conducted, the effect
of the interventions on smoking was approximately halved and
became marginally significant (p= 0.053).
DISCUSSION
Our findings are consistent with a previous systematic review
by Thomsen et al. (2014) and show that patients can effectively
be supported in stopping smoking before surgery. In 19 studies
involving randomized and quasi-experimental designs, the effect
of the interventions was to reduce smoking prevalence by half
at the time of surgery (effect size g = 0.56, 95% CI 0.32–0.80).
The results from the meta-analyses are unlikely to have been
influenced by risk of bias across the studies because the risk of
bias measures were unrelated to intervention effect sizes. The size
of the overall effect was also similar when the quasi-experimental
trials were excluded. In addition, we found that cessation support
may be optimized with the incorporation of specific intervention
components.
Behaviour Change Techniques
Of the BCTs, “provide information about the consequences
of smoking and smoking cessation” (BM1), was the most
Frontiers in Psychology | www.frontiersin.org 8 June 2017 | Volume 8 | Article 915
Prestwich et al. Pre-operative Smoking Cessation
TABLE 3 | Meta-regressions.
Predictor Expt.
group only
Both groups/
neither
Cont. group
only
RCTs + Quasi (k = 19) RCTs only (k = 16)
B 95% CI p-value B 95% CI p-value
Lower limit Upper limit Lower limit Upper limit
BM1Information on smoking/
cessation consequences
6 12 1 0.69 0.21 1.17 0.01** 0.75 0.22 1.28 0.01**
BM2 Boost
motivation/self-efficacy
4 15 0 0.25 −0.56 1.07 0.52 0.25 −0.66 1.15 0.57
BM9 Identify reasons for
wanting/not wanting to stop
4 14 1 0.51 −0.13 1.15 0.11 0.59 −0.17 1.34 0.12
BS4 Goal setting 8 11 0 0.54 −0.05 1.14 0.07† 0.77 0.13 1.40 0.02*
BS5 Review of goals 3 16 0 0.75 −0.11 1.61 0.08† 0.76 −0.16 1.69 0.10†
BS6 Self-recording 3 16 0 0.30 −0.58 1.18 0.48 0.23 −1.44 1.89 0.78
BS6b Regular monitoring by
others
2 17 0 1.32 0.34 2.29 0.01* 1.33 0.32 2.35 0.01*
BS7 Changing routine 2 17 0 0.22 −0.87 1.32 0.67 0.23 −1.44 1.89 0.78
BS8 Environmental
restructuring
1 17 1 0.63 −0.31 1.57 0.18 0.63 −0.38 1.64 0.20
BS9 Set graded tasks 2 17 0 -0.27 −1.31 0.78 0.60 -0.29 −1.44 0.85 0.59
BS10 Conserving mental
resources
2 17 0 -0.00 −1.05 1.05 0.99 -0.03 −1.18 1.25 0.96
A1 Advise on stop-smoking
medication
1 17 1 0.63 −0.31 1.57 0.18 0.63 −0.38 1.64 0.20
A2 Use of social support 4 14 1 0.19 −0.45 0.84 0.53 0.18 −0.58 0.94 0.62
A3 Enable clients to obtain
free medication
9 10 0 0.43 −0.19 1.04 0.16 0.50 −0.23 1.23 0.17
A5 Give options for extra
support
6 13 0 0.74 0.11 1.38 0.02* 0.85 0.13 1.58 0.03*
RD1 Tailor interactions 4 15 0 0.02 −0.81 0.85 0.96 0.02 −0.91 0.94 0.97
RC2 Elicit and answer
questions
3 16 0 0.19 −0.69 1.07 0.65 0.17 −0.97 1.30 0.76
RC6 Information on
withdrawal symptoms
2 16 1 0.80 0.12 1.48 0.02* 0.80 0.09 1.51 0.03*
RC10 Provide reassurance 2 17 0 0.22 −0.87 1.32 0.67 0.23 −1.44 1.89 0.78
Ext1 Benefits/harms
specified in context of
pre-op
6 13 0 -0.39 −1.06 0.28 0.23 -0.37 −1.22 0.49 0.37
Ext2 NRT, Verenicline or
Buproprion provided
10 9 0 0.37 −0.25 1.00 0.22 0.44 −0.31 1.19 0.23
*p < 0.05; **p < 0.01;
†
p < 0.10. Only the behavior change techniques that are used exclusively in one condition for at least 2 studies are reported. k,number of studies; RCTs,
Randomized controlled trials; Quasi, Quasi Experimental Trials; Expt. Group only indicates the number of studies that employed the behavior change technique only in the Experimental
group; Both groups/Neither indicates the number of studies that employed the behavior change technique in both experimental and comparison groups, or in neither; Cont. group only
indicates the number of studies that employed the behavior change technique only in the comparison condition. B, regression coefficient; 95%CI = 95% confidence interval.
Behavior change techniques regressed on smoking cessation effect sizes.
significant predictor of quitting successfully. This has significant
implications for pre-operative smoking cessation support. The
benefits of stopping smoking before surgery are substantially
different, and may be realized sooner, than the benefits
from smoking cessation in patients who are not scheduled
to have operations. Surveys of smokers’ knowledge suggest
that they are aware of the general health risks of smoking,
but under-appreciate that there are specific peri-operative
risks (Webb et al., 2013; Bottorff et al., 2015). However,
when controlling for other BCTs which were often delivered
alongside BM1, the effects drifted to non-significance. Given
the number of studies included in the review, and consequent
low power for such multivariate meta-analyses, these null
findings are perhaps unsurprising. However, it does highlight
the issue of potential confounding and indicates that effects,
at least in some instances, are not neatly attributed to a
single intervention component but potentially to a group of
intervention components.
Goal-setting was used frequently, was not confounded with
other BCTs or intervention features, andwas positively associated
with effect size. This suggests that goal-setting appears to be a
promising BCT to help smokers to abstain from smoking up to
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TABLE 4 | Meta-regressions.
Study characteristic k B RCTs + Quasi (k = 19) 95% CI RCTs only (k = 16)
Lower limit Upper limit p-value p-value
INTENSITY
Duration of delivery (intervention group, days) 16 0.01 0.002 0.019 0.02* 0.03*
Duration of intervention (relative to comparison group) 13 0.04 −0.02 0.10 0.13 0.17
Number of sessions (intervention group) 16 0.22 0.09 0.34 0.002** 0.001**
Number of sessions (relative to comparison group) 12 0.07 −0.42 0.57 0.75 0.80
MODE OF DELIVERY TO THE INTERVENTION GROUP
Face-to-face 19 0.21 −0.82 1.23 0.68 −
Internet/computer 19 −0.46 −1.42 0.50 0.32 0.32
Telephone 19 0.09 −0.58 0.76 0.78 0.80
Mail 19 0.34 −1.02 1.70 0.60 −
Print 19 −0.50 −1.11 0.10 0.099† 0.09†
MODEa
Face-to-face 19 0.77 0.14 1.39 0.02* 0.02*
Internet/computer 19 −0.46 −1.42 0.50 0.32 0.32
Telephone 19 0.36 −0.33 1.04 0.29 0.30
Mail 19 0.34 −1.02 1.70 0.60 −
Print 19 −0.27 −1.04 0.51 0.47 0.59
INTERVENTIONIST FOR THE EXPERIMENTAL CONDITIONb
Nurse 19 0.58 −0.01 1.17 0.05† 0.06
Anesthetist 19 −0.21 −1.08 0.66 0.62 0.59
Team 19 −0.32 −1.03 0.38 0.35 0.31
Clinician (doctor, anesthetist, surgeon, urologist) 19 −0.41 −1.10 0.28 0.23 0.20
INTERVENTIONISTc,d
Nurse 19 0.95 0.20 1.69 0.02* 0.02*
Team 19 −0.32 −1.03 0.38 0.35 0.63
Study characteristics other than behavior change techniques regressed on smoking cessation effect sizes.
* p < 0.05; **p < 0.01;
†
p < 0.10. k, number of studies; B, regression coefficient; 95%CI = 95% confidence interval; RCTs, randomized controlled trials; Quasi, Quasi-Experimental
Trials; aReflects the specific mode of delivery in the intervention group controlling for the equivalent mode in the comparison group. This was achieved by coding mode present as +1
and mode absent as 0 and then subtracting the mode of delivery in the comparison group from the mode of delivery in the intervention group. Thus, +1 reflects the intervention group
only used the specific mode; 0 reflects either both the intervention and comparison groups employed that mode, or neither; −1 reflects the comparison group only used the specific
mode of delivery. bRepeating these analyses after excluding the studies in which it was unclear who delivered the intervention did not significantly influence the findings (i.e., the marginal
effect remained marginal and the non-significant effects remained non-significant). cAdopts an equivalent approach to a. dResults not reported for anesthetist as there were no studies
in which the anesthetist delivered the intervention component without delivering the comparison component. Results not reported for clinician as only one study used a clinician to
deliver the intervention without using a clinician to deliver the comparison component.
the point of surgery with its effects not attributable to other BCTs
or intervention features.
Regular monitoring by others (BS6b) was also associated with
larger effect sizes and wasmarginally significant when controlling
for other related BCTs. However, regular monitoring appears to
be essential in light of the results from Shi et al.’s (2013) study
which indicated that informing participants that their smoking
intake would be monitored once on the day of surgery did
not increase abstinence rates relative to an otherwise equivalent
comparison group. Other BCTs that were initially associated with
effect sizes became non-significant when controlling for related
BCTs.
Intervention Intensity, Duration, and Mode
of Delivery
Thomsen et al.’s (2014) review suggested that intensive
interventions over multiple sessions were more successful than
brief interventions in aiding smoking cessation prior to surgery.
Taking a more fine-grained approach to the analyses, our
review identified a number of specific intervention components
reflecting a more intensive, longer-term approach to support
abstinence that were associated with higher rates of pre-operative
smoking cessation. In particular, delivering the interventions
over more sessions and for a longer duration, using regular
monitoring by others (BS6b), giving options for additional
and later support (A5), and using face-to-face delivery led
to higher rates of abstinence. The use of print materials
(e.g., provision of leaflets), which may be indicative of a
lower intensity intervention, was not helpful in trials to date.
Despite the relatively low power within the multivariate meta-
regressions, studies that delivered more sessions generated
larger effects that were robust when controlling for several
other significant intervention components including duration of
delivery.
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TABLE 5 | Risk of Bias.
Study Adequate
randomization?
Adequate allocation
concealment?
Adequate blinding
during pre-op?
Incomplete outcome
data addressed?
Free from selective
outcome reporting?
Andrews et al., 2006 Yes Yes Unclear Yes No
Haddock and Burrows, 1997 No No I/DC-No; P/DA-Unclear Yes Unclear
Haile et al., 2002, n/a n/a n/a Unclear Unclear
Kunzel et al., 2012 n/a n/a n/a Unclear Unclear
Lee et al., 2013 Yes Yes I-No; P/DC/DA-Unclear Yes No
Lindström et al., 2008 Yes Yes P/I/DA-No; DC-Unclear Yes Unclear
McHugh et al., 2001 Unclear Unclear P/I/DA-Unclear; DC-No Unclear Unclear
Møller et al., 2002 Yes Yes P/I/DA-No; DC-Unclear Yes Unclear
Munday et al., 1993 No No I/DC-No; P/DA-Unclear Unclear Unclear
Myles et al., 2004 Yes Unclear P/I-Yes;DC-Unclear;DA-No No Unclear
Ostroff et al., 2014 Yes Unclear Unclear Yes Unclear
Ratner et al., 2004 Yes Yes P/I/DA-No; DC-Unclear Unclear Unclear
Shah et al., 1984 No No I/DC-No; P/DA-Unclear Yes Unclear
Shi et al., 2013 Unclear Unclear No Unclear Unclear
Sørensen and Jørgensen, 2003 Yes Yes P/I/DA-No; DC-Unclear Unclear Unclear
Sørensen et al., 2007 Yes Yes No Unclear Unclear
Thomsen et al., 2010 Yes Yes P/I/DA-No; DC-Unclear Unclear Unclear
Walker et al., 2009 n/a n/a n/a Unclear Unclear
Warner et al., 2011 Yes Yes No Yes Unclear
Warner and Kadimpati, 2012 Yes Yes P/I-Yes; DC/DA-Unclear Yes Unclear
Wolfenden et al., 2005 Yes Unclear No Unclear Unclear
Wong et al., 2012 Yes Yes P/I/DC-Yes; DA-Unclear Yes No
P/I/DC/DA, Participant/Interventionist/Data Collector/Data Analyst; n/a, not applicable.
TABLE 6 | Significance of associations (p-values) between predictors of smoking cessation effect sizes.
Predictor 1 2 3 4 5 6 7 8 9 10 11 12
1. BM1: info. on smoking/cessation consequences – 0.27 0.35 0.09† 0.004** 0.000** 0.09† 0.006** 0.45 0.004** 0.03* 0.11
2. BS4: goal setting – 0.55 0.16 0.32 0.16 0.45 0.54 0.65 1.00 1.00 1.00
3. BS5: Review of goals – 0.02* 1.00 0.35 0.81 0.12 0.21 0.02* 0.23 0.004**
4. BS6b: regular monitoring by others – 1.00 0.15 0.81 0.04* 0.47 0.09† 0.49 0.04*
5. A5: give options for extra support – 0.68 0.17 0.11 0.63 0.05* 0.02* 0.37
6. RC6: Information on withdrawal symptoms – 0.88 0.01* 0.55 0.08† 0.24 0.52
7. Duration of delivery to intervention group – 0.001** 0.29 0.05† 0.27 0.006**
8. Number of sessions for those in the intervention – 0.25 0.002** 0.04* 0.001**
9. Intervention uses print materials – 0.63 0.37 0.09†
10. Face-to-face intervention vs. not in the comparison – 0.02* 0.004**
11. Nurse delivered the intervention – 0.10
12. Nurse delivered intervention vs. not in the comparison –
Fisher’s Exact Test p-value reported, where appropriate. *p < 0.05; **p < 0.01;
†
p < 0.10.
Personnel Delivering the Intervention
Of the interventionists, nurses were used most often and
appeared to be the most successful. This could be attributable
not only to their status as a credible source of information but
also reflect that they may have more time to deliver intensive
interventions relative to other healthcare professionals. Indeed,
nurses delivered interventions with more sessions and, after
controlling for the number of sessions, nurse-based interventions
were no longer associated with effect sizes. This suggests that
there is a trade-off to be made in busy pre-operative services that
aim to present patients for surgery within specified time frames
such as 18 weeks in the UK (NHS Clinical Services Team, 2015).
Nurses (and/or potentially others) delivering more sessions
should be more effective in increasing smoking abstinence in
the lead up to surgery but this may be difficult due to time
constraints.
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FIGURE 3 | Funnel Plot.
Important Gaps in the Literature
As well as highlighting intervention components that are
potentially effective in promoting smoking cessation in patients
about to undergo surgery, the review also highlights gaps
in the literature. For instance, a number of behavior change
techniques have not been tested in this context such as
providing rewards contingent on effort or progress and no
interventions were delivered to groups. These areas offer
potential because of evidence that providing contingent rewards
can be effective in reducing smoking (Giles et al., 2014) and
smoking-based interventions delivered to groups have been
found to be more effective than those delivered to individuals
(Bartlett et al., 2014).
Limitations
There were a number of limitations that should be discussed.
First, by not considering unpublished studies, the estimated
effects in this review may be overestimates, because published
articles may be more likely to report significant effects than
non-published articles. Indeed, relevant analyses suggested there
was some evidence of publication bias which, when accounted
for, the estimated effect size was halved. However, given
unpublished studies had not been peer reviewed and could
contain insufficient information, we anticipated that attempts to
code BCTs and other intervention content would be unreliable.
There is also the possibility that there may be differences
between the unpublished data/studies that authors were willing
to share and those studies for which authors were not willing to
share.
Second, there were relatively few studies meaning several
BCTs were used only in one study or not at all. The number of
studies analyzed also hindered the multivariate meta-regressions.
However, the risk of confounding remains an important
issue.
Third, the review could have been conducted using a broader
range of databases meaning there is a possibility that some
studies were missed. However, the review incorporates more
studies (22 studies) than those included in a recent Cochrane
review (Thomsen et al., 2014: 13 studies) and employed double-
screening which minimizes the risk that studies were excluded
in error. Moreover, it incorporated single group designs that
yielded results with some similarity with those generated from
the experimental trials, highlighting the possible effectiveness
of goal setting, providing additional support, and face-to-face
delivery.
Fourth, there is possibility of coding errors but coding was
checked by a second reviewer and we also coded intervention
components within the comparison conditions and took account
of this in our analyses. This has not always been done within
reviews attempting to identify which BCTs are effective in
changing health behaviors and related outcomes (Michie et al.,
2009; Dombrowski et al., 2012).
Finally, the average amount of time that patients were required
to be abstinent across the studies in this review was 7 days which,
in this setting, is perhaps understandable. However, this is a
very short period of time for smoking cessation. Indeed, none
of the studies included in this review that required smoking
cessation for 7 days or less detected significant differences
between the intervention and control conditions on rates of post-
operative complications; cessation over the longer-term seems
to be required to reduce post-operative complications (Møller
et al., 2002; Lindström et al., 2008). Given the focus of the
review on strategies to promote pre-operative smoking cessation
rates, we are unable to offer clear suggestions regarding what
should be done post-surgery with patients to promote cessation.
However, there is evidence that pre-operative smoking cessation
predicts cessation longer-term (Lee et al., 2015) thus achieving
brief cessation pre-surgery may be enough, for some patients,
to not smoke post-surgery. Interestingly, in an unpublished
service evaluation that we have conducted, interviewed patients
suggested that they wanted the emphasis to be on cessation
during the pre-operative period and not the longer term. Thus,
while one of the potential benefits of helping patients to abstain
from smoking during the pre-operative period is that they
are more likely to quit long-term, emphasizing longer-term
abstinence at the onset of the intervention may actually lower
engagement.
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CONCLUSION
The studies included in the review suggest that the percentage
of smokers who continue to smoke up until the point of surgery
can be halved, reflective of a medium effect size. However, there
was a risk of publication bias meaning the overall effect may
be smaller. Various intervention components were associated
with larger intervention effects but many of these are potentially
confounded. However, delivering more sessions, goal setting and,
to a lesser extent, regular monitoring of smoking by others were
robust against such confounds. Some intervention components
shown to be effective in reducing smoking in other populations,
such as delivering smoking cessation materials to groups, have
not been tested in patients awaiting surgery and could be usefully
tested by future research.
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